Curaleaf Holdings Inc (OTCMKTS:CURLF) recently announced its financial and operating results for the second quarter ended June 30, 2019. The company reported record quarterly pro forma revenue of $110.9 million, and managed revenue of $55.1 million and Adjusted EBITDA of $3.4 million. The stock initially reacted to the downside, but then found its footing and charged higher in an important technical victory for bulls.
Curaleaf Holdings Inc (OTCMKTS:CURLF) promulgates itself as a company that operates as an integrated medical and wellness cannabis operator in the United States.
The Company is the parent of Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf, Inc. has a presence in 12 states.
Curaleaf, Inc. operates 30 dispensaries, 12 cultivation sites and 9 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York. Curaleaf, Inc. leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy.
Curaleaf Inc.’s Florida operations were the first in the cannabis industry to receive the Safe Quality Food certification under the Global Food Safety Initiative, setting a new standard of excellence.
It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles.
The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of November 01, 2018, it operated a network of 29 dispensaries. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
CURLF has a significant war chest ($230.6M) of cash on the books, which is balanced by about $34.9M in total current liabilities.
Image Protect Inc (OTCMKTS:IMTL) is an interesting sub-penny story mostly because the company is working on something that could be a game-changer in the image-sharing cloud marketplace.
The company launched its Fotofy platform earlier this month, and just announced that it is nearing the launch of a powerful analytics dashboard to tie the platform functionality together as a strong user experience for image creators who want to monetize their creations with the company’s in-image ad model.
“The Dashboard launch is where this project really takes off,” commented Matthew Goldman, CEO of Image Protect. “This is the ‘killer app’ of the Fotofy ecosystem. It should glue all of this amazing functionality together in a truly intuitive way for users on the platform, allowing the user experience to mesh into the promise of the deeper opportunity for monetization, both for Image Protect shareholders and for our valued Image Rightsholders.”
Image Protect Inc (OTCMKTS:IMTL) protects and monetizes creative works.
By uniting technology with a team of copyright experts, the company seeks to ensure that content providers preserve the value of their digital assets. Its web application monitors the global Internet to seek and collect evidence for illegally used visual content.
Then, its legal partners across North America, Europe, and Asia ensure its clients receive appropriate compensation for work used without valid license.
IMTL is pulling in trailing 12-month revenues of $542K.
Abacus Health Products Inc (OTCMKTS:ABAHF) just announced that Rob Gronkowski, three-time professional football champion with several records to his name, has become an advocate for CBD and an investor in Abacus Health Products.
According to the release, Abacus is the maker of CBDMEDIC, the first family of all-natural topical medications that combine over the counter (OTC) drug active ingredients with CBD-rich hemp oil and other natural moisturizers. As part of the agreement, Gronkowski will partner with Abacus to expand CBDMEDIC’s product line, with new recovery solutions planned for 2020.
Abacus Health Products Inc (OTCMKTS:ABAHF) promulgates itself as a company that manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp.
The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils.
It also provides CBDMEDIC line of products, such as sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints.
The company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other OTC CBD products addressing additional medical indications and the health and wellness sectors.
And the stock has been acting well over recent days, up something like 27% in that time.